Abstract:BACKGROUND: Ataxia telangiectasia (AT) is characterized by cerebellar ataxia, telangiectasia, immunodeficiency, and increased cancer susceptibility and is caused by mutations in the ataxia telangiectasia mutated (ATM) gene. The immunodeficiency comprises predominantly immunoglobulin deficiency, mainly IgA and IgG2, with a variable severity. So far, the exact mechanisms underlying the immunoglobulin deficiency, especially the variable severity, remain unelucidated.OBJECTIVE: We characterized the clinical impact of immunoglobulin deficiencies in AT and elucidated their mechanisms in AT.METHODS: We analyzed long-term immunoglobulin levels, immunophenotyping, and survival time in our cohort (n = 87, median age 16 years; maximum 64 years). Somatic hypermutation and class-switch junctions in B cells were analyzed by next-generation sequencing. Furthermore, an in vitro class-switching induction assay was performed, followed by RNA sequencing, to assess the effect of ATM inhibition.RESULTS: Only the hyper-IgM AT phenotype significantly worsened survival time, while IgA or IgG2 deficiencies did not. The immunoglobulin levels showed predominantly decreased IgG2 and IgA. Moreover, flow cytometric analysis demonstrated reduced naive B and T lymphocytes and a deficiency of class-switched IgG2 and IgA memory B cells. Somatic hypermutation frequencies were lowered in IgA- and IgG2-deficient patients, indicating hampered germinal center reaction. In addition, the microhomology of switch junctions was elongated, suggesting alternative end joining during class-switch DNA repair. The in vitro class switching and proliferation were negatively affected by ATM inhibition. RNA sequencing analysis showed that ATM inhibitor influenced expression of germinal center reaction genes.CONCLUSION: Immunoglobulin deficiency in AT is caused by disturbed development of class-switched memory B cells. ATM deficiency affects both germinal center reaction and choice of DNA-repair pathway in class switching.

Telomerase activity, apoptosis and cell cycle progression in ataxia telangiectasia lymphocytes expressing TCL1

Cellular and molecular studies on ataxia-telangiectasia lymphoblastoid cell lines

Mutation Analysis of the Atm Gene in Two Chinese Patients with Ataxia Telangiectasia

Clustering of missense mutations in the ataxia-telanglectasia gene in a sporadic T-cell leukaemia

Immune profiling and functional analysis of NK and T cells in ataxia telangiectasia

Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia

Short Telomeres and Ataxia-Telangiectasia Mutated Deficiency Cooperatively Increase Telomere Dysfunction and Suppress Tumorigenesis

MicroRNA dysregulation in ataxia telangiectasia

Causative mechanisms and clinical impact of immunoglobulin deficiencies in ataxia telangiectasia

Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene

Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL

Dual Roles of ATM in the Cellular Response to Radiation and in Cell Growth Control.

Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing

ATM germline pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies

Myelin Pathology in Ataxia-Telangiectasia is the Cell Autonomous Effect of ATM Deficiency in Oligodendrocytes

ATM phosphorylation of CD98HC increases antiporter membrane localization and prevents chronic toxic glutamate accumulation in Ataxia telangiectasia

Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.

Ataxia Telangiectasia Mutant Protein Activates C-Abl Tyrosine Kinase in Response to Ionizing Radiation

High Recurrence of Rearrangements Involving Chromosome-14 in an Ataxia Telangiectasia Lymphoblastoid Cell-Line and in Its Mutagen-Treated Derivatives